NeoPharm Co Ltd

Chart & Performance

D1W1MN

P/E

6.59

P/S

1.28

EPS

2,949.22

Div Yield, %

—

Shrs. gr., 5y

15.64%

Rev. gr., 5y

7.41%

Revenues

119.01b

+22.56%

Net income

23.06b

-0.64%

CFO

18.63b

-19.91%

Dividend

Dec 27, 2023700 KRW/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. Its products include emulsified and functional skin care products for sensitive and dry skin, treatment of atopic dermatitis and psoriasis, and therapy for steroid side effects. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea.

URL

https://neopharm.co.kr/ko/default.do

IPO date

Jan 30, 2007

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT